Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E93.28 EPS (ttm)0.58 Insider Own0.50% Shs Outstand2.62B Perf Week2.66%
Market Cap138.27B Forward P/E21.79 EPS next Y2.48 Insider Trans0.00% Shs Float2.60B Perf Month0.43%
Income1.52B PEG4.88 EPS next Q0.46 Inst Own18.30% Short Float0.12% Perf Quarter23.07%
Sales25.25B P/S5.48 EPS this Y-39.70% Inst Trans-0.51% Short Ratio0.64 Perf Half Y8.01%
Book/sh4.11 P/B13.16 EPS next Y26.36% ROA2.50% Target Price55.27 Perf Year32.14%
Cash/sh1.63 P/C33.20 EPS next 5Y19.10% ROE12.30% 52W Range36.15 - 57.44 Perf YTD8.50%
Dividend1.40 P/FCF- EPS past 5Y1.00% ROI8.30% 52W High-5.81% Beta0.57
Dividend %2.59% Quick Ratio0.60 Sales past 5Y-1.70% Gross Margin79.60% 52W Low49.65% ATR1.23
Employees70600 Current Ratio0.80 Sales Q/Q15.70% Oper. Margin12.10% RSI (14)54.37 Volatility1.61% 1.93%
OptionableYes Debt/Eq1.72 EPS Q/Q27.00% Profit Margin6.00% Rel Volume1.04 Prev Close53.80
ShortableYes LT Debt/Eq1.49 EarningsJul 30 BMO Payout0.00% Avg Volume4.97M Price54.10
Recom1.50 SMA202.07% SMA501.74% SMA20011.60% Volume5,179,138 Change0.56%
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-06-20 12:19PM  
07:56AM  
02:07AM  
Jul-02-20 01:12PM  
Jul-01-20 11:40AM  
10:04AM  
09:25AM  
08:35AM  
Jun-30-20 12:46PM  
12:41PM  
08:08AM  
Jun-29-20 06:57PM  
02:06PM  
01:26PM  
02:40AM  
02:00AM  
Jun-27-20 10:50AM  
Jun-26-20 04:54PM  
10:35AM  
09:44AM  
09:44AM  
09:21AM  
04:48AM  
Jun-25-20 07:00AM  
Jun-24-20 04:53PM  
03:08PM  
02:48PM  
01:15PM  
11:05AM  
10:10AM  
09:39AM  
04:53AM  
Jun-23-20 05:24PM  
03:28PM  
11:15AM  
10:47AM  
06:08AM  
01:00AM  
Jun-22-20 12:52PM  
Jun-21-20 07:15PM  
Jun-20-20 12:11PM  
Jun-19-20 11:58AM  
07:25AM  
Jun-18-20 10:31AM  
06:39AM  
06:31AM  
Jun-17-20 07:48AM  
06:33AM  
Jun-16-20 04:28PM  
11:30AM  
10:36AM  
09:51AM  
08:41AM  
04:33AM  
04:05AM  
Jun-15-20 05:00PM  
01:45PM  
01:05PM  
11:54AM  
11:49AM  
11:37AM  
10:46AM  
10:26AM  
10:04AM  
09:53AM  
09:36AM  
08:32AM  
07:46AM  
06:51AM  
05:59AM  
05:57AM  
05:57AM  
05:32AM  
Jun-14-20 11:16AM  
03:57AM  
02:20AM  
Jun-13-20 11:58AM  
10:46AM  
09:09AM  
08:58AM  
08:21AM  
Jun-12-20 08:54AM  
08:51AM  
08:30AM  
04:37AM  
Jun-11-20 10:15PM  
02:42PM  
02:34PM  
02:15PM  
11:37AM  
10:56AM  
10:29AM  
09:06AM  
09:03AM  
07:01AM  
Jun-10-20 07:19PM  
04:52PM  
02:55PM  
02:22PM  
01:30PM  
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 07Buy19.00425,0008,075,00014,650,334Oct 09 04:53 PM